Citation

William T. Shearer, M.D., Ph.D., Howard Max Rosenblatt, M.D., Stephen A. Spector, M.D., E. Richard Stiehm, M.D., Diane W. Wara, M.D., Steven D. Douglas, M.D., Katherine Luzuriaga, M.D., Elizabeth (Betsy) J. McFarland, M.D., Ram Yogev, M.D., Mobeen H. Rathore, M.D., Wende Levy, R.N., M.S., Barney S. Graham, M.D., Ph.D., Rebecca Oyomopito, M.S., Rebecca S. Gelman, Ph.D. Age-related expression of naive (CD45RA/62L) and activation (HLADR/CD38) surface markers on CD4+ T-cells in normal children (birth to 18 years). Journal of Allergy and Clinical Immunology. 2002 Dec 23; 109(1):S199.

Citation

Mohammed M. Hossain, Jason J. Coull, George Drusano, M.D., David M. Margolis, M.D. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Research. 2002 Jul 01; 55(1):41-52.

Citation

Jeannette Ickovics, Ph.D., C.S. Meade. Adherence to HAART among patients with HIV: breakthroughs and barriers. AIDS Care. 2002 Jun 01; 14(3):309-18.

Citation

Peter Anderson, Pharm.D., Richard Brundage, Pharm.D., Ph.D., Thomas N Kakuda, Pharm.D., Courtney V. Fletcher, Pharm.D. CD4 response is correlated with peak plasma concentrations of indinavir in adults with undetectable human immunodeficiency virus ribonucleic acid. Clinical Pharmacology & Therapeutics. 2002 Apr 01; 71(4):280-5.

Citation

A. P. Fitzgerald, Victor DeGruttola, Sc.D., Florin Vaida, Ph.D. Modelling HIV viral rebound using non-linear mixed effects models. Statistics In Medicine. 2002 Jul 30; 21(14):2093-108.

Citation

Mark Mirochnick, M.D., Ellen Rae Cooper, M.P.H., M.D., Edmund Capparelli, Pharm.D., Kenneth McIntosh, M.D., Jane C. Lindsey, Sc.D., Jing Xu, M.S., David P. Jacobus, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Vincent R. Bonagura, M.D., Sharon Appelbaum Nachman, M.D., Ram Yogev, M.D., John L. Sullivan, M.D., Stephen A. Spector, M.D. Population pharmacokinetics of dapsone in children with human immunodeficiency virus infection. Clinical Pharmacology & Therapeutics. 2001 Jul 31; 70(1):24-32.

Citation

Edmund Capparelli, Pharm.D., John L. Sullivan, M.D., Lynne M. Mofenson, M.D., F.A.A.P., Elaine Margaret Smith, M.D., Bobbie L. Graham, B.S., Bobbie L. Graham, B.S., Paula Britto, M.S., Mark I. Becker, Pharm.D., Diane Holland, M.Phil., James D. Connor, M.D., Katherine Luzuriaga, M.D. Pharmacokinetics of nelfinavir in human immunodeficiency virus-infected infants. Pediatric Infectious Disease Journal. 2001 Sep 24; 20(8):746-51.

Citation

Elizabeth (Betsy) J. McFarland, M.D., William Borkowsky, M.D., Terence Fenton, Ed.D., Diane W. Wara, M.D., James McNamara, M.D., Pearl Samson, M.S., Minhee Kang, M.S., Ph.D., Lynne M. Mofenson, M.D., F.A.A.P., Coleen K. Cunningham, M.D., Anne-Marie Duliege, M.D., M.S., Faruk Sinangil, Stephen A. Spector, M.D., Eleanor Jimenez, M.D., F.A.A.P., Yvonne J. Bryson, M.D., Sandra K. Burchett, M.D., M.S., Lisa M. Frenkel, M.D., Ram Yogev, M.D., Francis Gigliotti, M.D., Katherine Luzuriaga, M.D., Robert Livingston, M.D. Human Immunodeficiency Virus type 1 (HIV-1) gp120-specific antibodies in neonates receiving an HIV-1 recombinant gp120 vaccine. Journal of Infectious Diseases. 2001 Nov 30; 184(10):1331-1335.

Citation

Laura Smeaton, M.S., Victor DeGruttola, Sc.D., Gregory K. Robbins, M.D., M.P.H., Robert Shafer, M.D. ACTG (AIDS Clinical Trials Group) 384: A strategy trial comparing consecutive treatments for HIV-1. Controlled Clinical Trials. 2001 Apr 01; 22(2):142-59.